The Irishman, This is exactly why GIA is suicide...at least in the US. Without the bundled drug approach that BP is able to offer, AMRN is at a severe disadvantage. A seasoned drug executive should have understood that before deciding to hire his own 800 strong sales force. This is what makes JT's GIA decision so absurd. Right now it does seem as if JT is serious about GIA in Europe...so no BP BO. (Hope I am wrong.)